PRESS RELEASE published on 08/25/2025 at 08:00, 8 months 17 days ago Informations privilégiées / Autres communiqués TME Pharma lève 500 000 € via une émission obligataire pour accélérer ses activités de développement de thérapies innovantes. Nouveau soutien financier renforce la position de TME Pharma Développement Financement Émission Obligataire TME Pharma Thérapies Innovantes
BRIEF published on 07/08/2025 at 08:05, 10 months 3 days ago TME Pharma met fin à son contrat de liquidité dans le cadre d'une optimisation des coûts Contrat De Liquidité Biotechnologie Optimisation Des Coûts Refinancement TME Pharma
BRIEF published on 07/08/2025 at 08:05, 10 months 3 days ago TME Pharma Terminates Liquidity Contract Amid Cost Optimization Liquidity Contract Biotechnology Refinancing Cost Optimization TME Pharma
PRESS RELEASE published on 07/08/2025 at 08:00, 10 months 3 days ago Informations privilégiées / Autres communiqués TME Pharma annonce la résiliation du contrat de liquidité avec Invest Securities pour optimiser ses coûts et renforcer sa trésorerie. Réduction des coûts opérationnels suite à la restructuration organisationnelle Contrat De Liquidité Optimisation Des Coûts TME Pharma Restructuration Organisationnelle Développement Thérapies
PRESS RELEASE published on 07/08/2025 at 08:00, 10 months 3 days ago Inside Information / Other news releases TME Pharma terminates liquidity contract with Invest Securities to optimize costs. Improve trading volume of shares and healthy liquidity deemed contract unnecessary. Finds success in refinancing and reducing operational costs Liquidity Contract Cost Optimization Trading Volume Organizational Restructuring TME Pharma
BRIEF published on 05/21/2025 at 08:05, 11 months 21 days ago TME Pharma Enhances Financial Outlook with €1.7M Bond Commitments Strategic Partnerships Bond Issuance Clinical Programs Financial Visibility Cost Structure
BRIEF published on 05/21/2025 at 08:05, 11 months 21 days ago TME Pharma améliore ses perspectives financières avec un engagement obligataire de 1,7 million d'euros Partenariats Stratégiques Emission D'obligations Programmes Cliniques Visibilité Financière Structure Des Coûts
PRESS RELEASE published on 05/21/2025 at 08:00, 11 months 21 days ago Informations privilégiées / Autres communiqués TME Pharma, société de biotechnologie spécialisée en thérapies contre le cancer, prolonge sa visibilité financière jusqu'en mai 2026 via une émission d'obligations aux investisseurs professionnels Investisseurs Obligations Cancer Visibilité Financière TME Pharma
PRESS RELEASE published on 05/21/2025 at 08:00, 11 months 21 days ago Inside Information / Other news releases TME Pharma extends financial visibility to May 2026 by securing €1.7M financing through regular bonds with attached warrants. CEO and board show strong commitment to company's success Clinical Programs TME Pharma Financial Visibility Regular Bonds Private Warrants
BRIEF published on 04/10/2025 at 19:05, 1 year 1 month ago TME Pharma strengthens its liquidity contract with Invest Securities Liquidity Contract Oncology INVEST SECURITIES Financial Markets TME Pharma
Published on 05/12/2026 at 06:00, 16 minutes ago NOA Lithium Announces Strategic Collaboration with Hidrotec to Support NOA Projects
Published on 05/12/2026 at 04:20, 1 hour 56 minutes ago AI/ML Innovations Inc. Announces Closing of Final Tranche of Private Placement to Raise $1,917,500
Published on 05/12/2026 at 03:05, 3 hours 11 minutes ago UraniumX Reports Tragic Incident at Its Zoo Bay Property
Published on 05/12/2026 at 00:00, 6 hours 16 minutes ago PPX Mining Provides Update on Start-up of the Process Plant
Published on 05/12/2026 at 00:00, 6 hours 16 minutes ago Redwood AI Included in Innovate BC Investor Showcase: BC's Top 25 Investible Companies Event
Published on 05/12/2026 at 01:10, 5 hours 5 minutes ago Monport Brings Advanced Laser Machine With The New Mega S and UV Laser Technology in Germany
Published on 05/12/2026 at 00:19, 5 hours 57 minutes ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA adjusts its forecast for 2026 and complies with the obligation to report losses pursuant to Section 92 of Stock Corporation Act (AktG) – Draft restructuring report submitted
Published on 05/11/2026 at 22:05, 8 hours 11 minutes ago Abivax annonce les résultats de son Assemblée Générale du 11 mai 2026
Published on 05/11/2026 at 22:05, 8 hours 11 minutes ago Abivax Announces Results of its May 11, 2026 Annual General Meeting
Published on 05/11/2026 at 21:16, 8 hours 59 minutes ago Original-Research: Intershop Communications (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 05/11/2026 at 19:02, 11 hours 13 minutes ago 260511 BENETEAU Transactions sur actions propres
Published on 05/11/2026 at 18:18, 11 hours 57 minutes ago Reporting on share buyback transactions carried out between May 4 and May 5, 2026
Published on 05/11/2026 at 18:18, 11 hours 57 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain les 4 et 5 mai 2026
Published on 05/11/2026 at 18:14, 12 hours 1 minute ago Nombre total d'actions et droits de vote - avril 2026
Published on 05/11/2026 at 18:14, 12 hours 1 minute ago Number of shares and voting rights - April 2026 (In French only)
